Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 36, 2002 - Issue 5
Submit an article Journal homepage
44
Views
10
CrossRef citations to date
0
Altmetric
Research Article

An Organ-sparing Treatment Using Combined Intra-arterial Chemotherapy and Radiotherapy for Muscle-invading Bladder Carcinoma

Sadamu Tsukamoto Department of Urology, Hitachi, Ltd., Hitachi General Hospital, Ibaraki, Japan and Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan
,
Satoru Ishikawa Department of Urology, Hitachi, Ltd., Hitachi General Hospital, Ibaraki, Japan
,
Masakazu Tsutsumi Department of Urology, Hitachi, Ltd., Hitachi General Hospital, Ibaraki
,
Kotaro Nakajima Department of Radiology, Hitachi, Ltd., Hitachi General Hospital, Ibaraki, Japan
&
Shinji Sugahara Department of Radiology, Hitachi, Ltd., Hitachi General Hospital and Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan
Pages 339-343 | Published online: 09 Jul 2009

  • Raghavan D, Shipley WU, Garnick MB, Russell PJ, Richie JP. Biology and management of bladder cancer. N Engl J Med 1990; 322: 1129-38.
  • Skinner DG, Stein JP, Lieskovsky G, Skinner EC, Boyd SD, Figueroa A, et al. 25-year experience in the management of invasive bladder cancer by radical cystectomy. Eur Urol 1998; 33 (Suppl 4): 25-6.
  • Sternberg CN, Yagoda A, Scher HI, Watson RC, Geller N, Herr HW, et al. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer 1989; 64: 2448-58.
  • Scher H, Herr H, Sternberg C, Fair W, Bosl G, Morse M, et al. Neo-adjuvant chemotherapy for invasive bladder cancer: experience with the M-VAC regimen. Br J Urol 1989; 64: 250-6.
  • Shipley WU, Winter KA, Kaufman DS, Lee WR, Heney NM, Tester WR, et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder canceltreated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 1998; 16: 3576-83.
  • Fellin G, Graffer U, Bolner A, Ambrosini G, Caffo O, Luciani E. Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study. Br J Urol 1997; 80:44-9.
  • Tester W, Caplan R, Heaney J, Venner P, Whittington R, Byhardt R, et al. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802. J Clin Oncol 1996; 14: 119-26.
  • Kachnic LA, Kaufman DS, Heney NM, Althausen AF, Griffin PP, Zietman AL, et al. Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol 1997; 15: 1022-9.
  • Eapen E, Stewart D, Danjoux C, Genest P, Futter N, Moors D, et al. Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancer. J Clin Oncol 1989; 7: 230-5.
  • Mokarim A, Uetani M, Hayashi N. Combined intraarterial chemotherapy and radiotherapy in the treatment of bladder carcinoma. Cancer 1997; 80: 1776-85.
  • Terashima Y. CDDP concentration of bladder tumors--comparison between intraarterial infusion and intravenous infusion. Nippon Gan Chiryo Gakkai Shi 1988; 23: 859-66.
  • Okada H, Oguchi N, Uchida J, Mikami O, Matsuda T. Study on platinum concentration in internal iliac venous blood after iliac artery cisplatin infusion for invasive bladder cancer. Hinyokika Kiyo 1999; 45: 145-8.
  • Stewart DJ, Benjamin RS, Zimmerman S, Caprioli RM, Wallace S, Chuang V, et al. Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II). Cancer Res 1983; 43: 917-20.
  • Sumiyoshi Y, Hashine K, Nakatsuji H. Intra-arterial chemotherapy in combination with radiotherapy for invasive bladder cancer and prostate cancer. Hinyokika Kiyo 1999; 45: 155-8.
  • Miyanaga N, Akaza H, Okumura T, Sekido N, Kawai K, Shimazui T, et al. A bladder preservation regimen using intra-arterial chemotherapy and radiotherapy for invasive bladder cancer a prospective study. Int J Urol 2000; 7: 41-8.
  • Uchida J, Okada H, Ohguchi N, Kawa G, Koyama Y, Mikami O, et al. Comparison of side effects caused by intra-arterial and intravenous infusion of M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) for urothelial cancer Hinyokika Kiyo 1997; 43: 637-40.
  • Stewart DJ, Eapen L, Hirte WE, Futter NG, Moors DE, Murphy PG, et al. Intra-arterial cisplatin for bladder cancer. J Urol 1987; 138: 302-5.
  • Gotoh S, Fukui I, Kobayashi T, Kihara K, Kitahara S, Oshima H, et al. Intra-arterial CDDP and CDDP plus THP-ADM therapy for bladder cancer Nippon Hinyokika Gakkai Zasshi 1993; 84: 1865-71.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.